← Leaderboards
Stanislav Roslyakov
Addinex Technologies, Inc.
$868,493
Attributed
$868,493
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $313K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$608,934 · 2
CDC$259,559 · 1
By mechanism
R43$868,493 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseMonitorOpioidPharmaceutical PreparationsLegal PatentCollaborationsCostTechnologyPharmacy FacilityPharmacistsPillSurveysHospitalsCommercializationCodeAddictionFeedbackSecureOverdose DeathDevicesAftercareDoctor Of PhilosophyData AnalyticsCosts And Benefits
Grant awards (4)
Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder$306,528
R43 · FY2025 · DA · contact PI
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients$6,500
R43 · FY2025 · DA · contact PI
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients$295,906
R43 · FY2024 · DA · contact PI
Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD)$259,559
R43 · FY2021 · CE · contact PI